Molecumetics: Superfamily scaffolds

Emerging Company Profile

Working from the general to the specific is one way to learn how to discover new drugs. That's the strategy being pursued by Molecumetics Ltd., which conducts drug discovery by starting with the similarities among protein superfamilies and works down to the specific differences between individual drug targets.

Molecumetics concentrates its drug design efforts initially on choosing a scaffold that interacts with a particular protein superfamily - proteases, for example

Read the full 733 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE